The Medicines Control Authority of Zimbabwe (MCAZ) has issued a Class II recall for a specific batch of YAZ Plus contraceptive tablets. The affected batch, registered as 2022/21.2.1/6235, with batch number WEW961J, was manufactured by Bayer (Pty) Ltd in South Africa.
The recall was prompted by a packaging error discovered in some packs of the affected batch, where 24 light orange hormone-free tablets and 4 pink hormone tablets were found.
The correct configuration should be 24 pink hormone tablets and 4 light orange hormone-free tablets.
This discrepancy could potentially compromise the effectiveness of the contraceptive, posing risks to users.
MCAZ emphasises that this recall is a precautionary measure to safeguard public health, as the non-compliance with quality specifications may result in reduced efficacy and potential harm.
Public Advisory
MCAZ has instructed all licensed wholesalers, pharmacies, clinics, and hospitals to quarantine any affected units of YAZ Plus.
Healthcare providers and distributors are expected to collaborate with Bayer (Pty) Ltd and local distributors in Zimbabwe to facilitate the recall.
Instructions for Users
Consumers currently using YAZ Plus should check the batch number on their packs. If the batch matches WEW961J, users are advised to stop taking the medication immediately.
Affected packs should be returned to pharmacies, and individuals should consult healthcare professionals for guidance.
For further information, stakeholders can reach out to the MCAZ at: mcaz@mcaz.co.zw
This alert underscores MCAZ’s commitment to ensuring public safety and maintaining quality standards in pharmaceuticals.
Issued by:
Richard T Rukwata
Director-General, MCAZ